Keep pulling the thread on Home Depot.
Solugen has invented a process called 'chemoenzymatic processing' which pairs an enzyme with a metal catalyst to produce chemicals.
Solugen's chemoenzymatic process achieves a 96% reaction yield at scale, a significant improvement over traditional methods that might yield 60%.
The high concentration of hydrogen peroxide observed in pancreatic cancer is caused by a specific mutated enzyme unique to those cancer cells.
Solugen's manufacturing process utilizes enzymes originally identified in pancreatic cancer cells to transform corn syrup into new chemical compounds.
Solugen raised a $4 million seed round after completing the Y Combinator program.
A single 'Coke bottle' volume of Solugen's proprietary enzyme can produce enough final chemical product to fill two to four tanker trucks.
Solugen is a company with a valuation of over one billion dollars.
Solugen invented a proprietary manufacturing method called "chemoenzymatic processing" which combines enzymes with metal catalysts.
Solugen's chemoenzymatic process achieves a 96% reaction yield at scale, a significant improvement over the 60% yield of traditional chemical processes.
Solugen adopted a capital-efficient strategy of building a small-scale reactor and selling to customers immediately, contrasting with previous industry startups that raised large funds to build large plants upfront.
A key part of Solugen's competitive strategy is to build multiple, smaller factories near customers to minimize shipping costs and undercut larger competitors.
Solugen sells chemical products for industries including water treatment, national defense, infrastructure, and agriculture.